Equity Overview
Price & Market Data
Price: $0.259
Daily Change: -$0.0137 / 5.29%
Daily Range: $0.254 - $0.273
Market Cap: $7,110,516
Daily Volume: 78,652
Performance Metrics
1 Week: -10.62%
1 Month: -6.03%
3 Months: -51.29%
6 Months: -87.93%
1 Year: -94.31%
YTD: -84.51%
Company Details
Employees: 16
Sector: Health technology
Industry: Biotechnology
Country:
Details
Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.